Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
7.85M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
183K
-
Shares change
-
-155K
-
Total reported value, excl. options
-
$162K
-
Value change
-
-$141K
-
Number of buys
-
7
-
Number of sells
-
-5
-
Price
-
$0.89
Significant Holders of Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) as of Q4 2024
17 filings reported holding SILO - Silo Pharma, Inc. - Common stock, par value $0.0001 per share as of Q4 2024.
Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 183K shares
of 7.85M outstanding shares and own 2.32% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (37.5K shares), GEODE CAPITAL MANAGEMENT, LLC (34.9K shares), UBS Group AG (20.1K shares), VANGUARD GROUP INC (16.3K shares), XTX Topco Ltd (14.6K shares), STATE STREET CORP (12.5K shares), HRT FINANCIAL LP (11.4K shares), TWO SIGMA SECURITIES, LLC (11.4K shares), Virtu Financial LLC (10.4K shares), and Federation des caisses Desjardins du Quebec (6K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.